Clinical validation of the Lumipulse G cerebrospinal fluid assays for routine diagnosis of Alzheimer's disease.

Maria João LeitãoAnuschka Silva-SpínolaIsabel SantanaVeronica OlmedoAlicia NadalNathalie Le BastardInês Baldeiras

Published in: Alzheimer's research & therapy (2019)

The Lumipulse G assays show a very good analytical performance that makes them well-suited for CSF clinical routine measurements. The good clinical concordance between the Lumipulse G and INNOTEST assays facilitates the implementation of the new method in routine practice.

Keyphrases

cerebrospinal fluid
healthcare
high throughput
primary care
cognitive decline
single cell